Services

Real-World Evidence Support Across the Full Evidence Lifecycle

RWAnalytica supports pharmaceutical and biotechnology organizations before, during, and after key product milestones — from evidence strategy through observational research to dissemination.

Phase 01

Before the Study

Helping clients ask the right questions before investing in evidence generation.

What we do

  • Evidence strategy
  • Integrated evidence planning
  • Evidence gap assessments
  • Research prioritization
  • Data source selection
  • Feasibility studies
  • Regulatory evidence planning

Questions we answer

  • Is real-world evidence the right approach?
  • Which data source should we use?
  • Is the study feasible?
  • What evidence do regulators expect?

Phase 02

During the Study

Designing and executing scientifically rigorous observational research.

What we do

  • Protocol development
  • Statistical analysis plan
  • Comparative effectiveness studies
  • Drug safety studies
  • Target trial emulation
  • Validation studies
  • Benefit-risk analyses
  • Advanced statistical analyses

Example study types

  • Comparative effectiveness
  • Drug safety
  • Treatment switching
  • Persistence and adherence
  • Treatment duration
  • External control arms
  • Post-marketing surveillance

Phase 03

After the Study

Helping clients maximize the value of the evidence they generate.

Dissemination & application

  • Technical reports
  • Publications
  • Conference posters or presentations
  • Regulatory submissions

 

  • Medical affairs materials
  • Field evidence decks
  • Payer value propositions
  • Scientific slide presentations

Advanced Scientific Expertise

Some questions demand more than a standard analysis.

Some research questions require advanced epidemiologic methods to produce valid, decision-ready evidence.

Target trial emulation Causal inference Marginal structural models Clone-censor-weighting Propensity score methods Time-varying exposure analyses Comparative effectiveness research Systematic reviews Meta-analysis

Therapeutic Experience

Depth across the therapeutic areas where RWE matters most.

Oncology
Diabetes
Obesity
Cardiovascular disease
Neurology
Women's health
Respiratory medicine
Rare diseases

Real-World Data Experience

Experience with the databases regulators and payers recognize.

Working across leading electronic health record, claims, registry, and linked healthcare databases — including CPRD studies and other healthcare database studies.

Electronic Health Records

  • Clinical Practice Research Datalink (CPRD) linked to Hospital Episode Statistics and/or Civil Registrations of Death
  • Optum
  • Flatiron Health

Administrative Claims

  • MarketScan
  • Medicare
  • Optum

Registries & Networks

  • SEER-Medicare
  • TriNetX
  • Observational Medical Outcomes Partnership (OMOP) databases
  • National registries

Who We Work With

Partners across the evidence ecosystem.

Pharmaceutical companies
Biotechnology companies
Medical device companies
Legal organizations
Academic institutions

Let’s Talk

Need support with a real-world evidence project?

Whether you need strategic guidance, advanced methodology, or end-to-end study support, RWAnalytica can help.